DSGN
Price
$3.97
Change
-$0.38 (-8.74%)
Updated
Aug 7 closing price
Capitalization
225.37M
89 days until earnings call
NTLA
Price
$11.46
Change
+$0.09 (+0.79%)
Updated
Aug 7 closing price
Capitalization
1.19B
90 days until earnings call
Interact to see
Advertisement

DSGN vs NTLA

Header iconDSGN vs NTLA Comparison
Open Charts DSGN vs NTLABanner chart's image
Design Therapeutics
Price$3.97
Change-$0.38 (-8.74%)
Volume$61.87K
Capitalization225.37M
Intellia Therapeutics
Price$11.46
Change+$0.09 (+0.79%)
Volume$5.83M
Capitalization1.19B
DSGN vs NTLA Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. NTLA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (DSGN: $3.97 vs. NTLA: $11.47)
Brand notoriety: DSGN and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 68% vs. NTLA: 121%
Market capitalization -- DSGN: $225.37M vs. NTLA: $1.19B
DSGN [@Biotechnology] is valued at $225.37M. NTLA’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • NTLA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than NTLA.

Price Growth

DSGN (@Biotechnology) experienced а +2.58% price change this week, while NTLA (@Biotechnology) price change was -1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.19B) has a higher market cap than DSGN($225M). NTLA YTD gains are higher at: -1.629 vs. DSGN (-35.656). DSGN has higher annual earnings (EBITDA): -67.79M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. DSGN (230M). DSGN has less debt than NTLA: DSGN (2.14M) vs NTLA (119M). NTLA has higher revenues than DSGN: NTLA (45.6M) vs DSGN (0).
DSGNNTLADSGN / NTLA
Capitalization225M1.19B19%
EBITDA-67.79M-530.8M13%
Gain YTD-35.656-1.6292,188%
P/E RatioN/AN/A-
Revenue045.6M-
Total Cash230M504M46%
Total Debt2.14M119M2%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNNTLA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KSMIX9.56N/A
N/A
Keeley Gabelli SMID Cap Value I
MSFRX19.65N/A
N/A
MFS Total Return A
MASGX13.05N/A
N/A
Matthews Emerging Markets Sust Fut Inv
BDFFX32.93N/A
N/A
Baron Discovery Retail
VTAIX11.27N/A
N/A
Virtus Tactical Allocation I

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-8.74%
VRDN - DSGN
49%
Loosely correlated
-3.90%
IDYA - DSGN
49%
Loosely correlated
-5.16%
AURA - DSGN
46%
Loosely correlated
-1.21%
TRDA - DSGN
46%
Loosely correlated
-10.92%
NTLA - DSGN
45%
Loosely correlated
+0.88%
More